2019

December 2019

• miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker. Nadaradjane A, Briand J, Bougras-Cartron G, Disdero V, Vallette FM, Frenel JS, Cartron PF. Mol Ther Nucleic Acids. 2018 Dec 7;13:642-650. doi: 10.1016/j.omtn.2018.09.007.

November 2019

• Diuron exposure and Akt overexpression promote glioma formation through DNA hypomethylation. Briand J, Nadaradjane A, Bougras-Cartron G, Olivier C, Vallette FM, Cartron PF. Clin Epigenetics. 2019 Nov 14;11(1):159. doi: 10.1186/s13148-019-0759-1.
• Interplay between transcription regulators RUNX1 and  FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. Debaize L, Jakobczyk H, Avner S, Gaudichon J, Rio AG, Sérandour AA, Dorsheimer  L, Chalmel F, Carroll JS, Zörnig M, Rieger MA, Delalande O, Salbert G, Galibert  MD, Gandemer V, Troadec MB.        Nucleic Acids Res. 2018 Nov 30;46(21):11214-11228.
• Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M, McPherson JD, O'Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman SV, Hung RJ, De Carvalho DD. Nature. 2018 Nov;563(7732):579-583. doi: 10.1038/s41586-018-0703-0.
• RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature. Le Caignec C, Ory B, Lamoureux F, O'Donohue MF, Orgebin E, Lindenbaum P, Téletchéa S, Saby M, Hurst A, Nelson K, Gilbert SR, Wilnai Y, Zeitlin L, Segev E, Tesfaye R, Nizon M, Cogne B, Bezieau S, Geoffroy L, Hamel A, Mayrargue E, de Courtivron B, Decock-Giraudaud A, Charrier C, Pichon O, Retière C, Redon R, Pepler A, McWalter K, Da Costa L, Toutain A, Gleizes PE, Baud'huin M, Isidor B. Am J Hum Genet. 2019 Nov 7;105(5):1040-1047.

October 2019

• Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors. Autin P, Blanquart C, Fradin D. Cancers (Basel). 2019 Oct 10;11(10). pii: E1530. doi: 10.3390/cancers11101530.

September 2019

• Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner. Duforestel M, Nadaradjane A, Bougras-Cartron G, Briand J, Olivier C, Frenel JS, Vallette FM, Lelièvre SA, Cartron PF. Front Genet. 2019 Sep 27;10:885. doi: 10.3389/fgene.2019.00885.
• Hybrid Azo-fluorophore Organic Nanoparticles as Emissive Turn-on Probes for Cellular Endocytosis. Boucard J, Briolay T, Blondy T, Boujtita M, Nedellec S, Hulin P, Grégoire M, Blanquart C, Ishow E. ACS Appl Mater Interfaces. 2019 Sep 11;11(36):32808-32814. doi: 10.1021/acsami.9b12989.
• A five-CpG signature of microRNA methylation in non-G-CIMP glioblastoma. Kang EM, Yin AA, He YL, Chen WJ, Etcheverry A, Aubry M, Barnholtz-Sloan J, Mosser J, Zhang W, Zhang X. CNS Neurosci Ther. 2019 Sep;25(9):937-950.

August 2019

• Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy. Bordron A, Bagacean C, Mohr A, Tempescul A, Bendaoud B, Deshayes S, Dalbies F, Buors C, Saad H, Berthou C, Pers JO, Renaudineau Y. Oncotarget. 2018 Aug 3;9(60):31590-31605. doi: 10.18632/oncotarget.25657. eCollection 2018 Aug 3.

July 2019

• Epigenetic metalloenzymes. Blanquart C, Linot C, Cartron PF, Tomaselli D, Mai A, Bertrand P. Curr Med Chem.
  Curr Med Chem 2019;26(15):2748-2785. doi: 10.2174/0929867325666180706105903.

May 2019

• Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling. Bouchet S, Linot C, Ruzic D, Agbaba D, Fouchaq B, Roche J, Nikolic K, Blanquart C, Bertrand P. ACS Med Chem Lett. 2019 May 9;10(6):863-868. doi: 10.1021/acsmedchemlett.8b00440.
• Correction to: Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016. Compes P, Tabouret E, Etcheverry A, Colin C, Appay R, Cordier N, Mosser J, Chinot O, Delingette H, Girard N, Dufour H, Metellus P, Figarella-Branger D. J Neurooncol. 2019 May;142(3):521
• Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas. Yin AA, He YL, Etcheverry A, Liu YH, Aubry M, Barnholtz-Sloan J, Liu BL, Mosser J, Lu ZF, Zhang X. Clin Epigenetics. 2019; 11: 76.
  Published online 2019 May 14. doi: 10.1186/s13148-019-0670-9

April 2019

• Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer. Vallette FM, Olivier C, Lézot F, Oliver L, Cochonneau D, Lalier L, Cartron PF, Heymann D. Biochem Pharmacol. 2019 Apr;162:169-176. doi: 10.1016/j.bcp.2018.11.004. Epub 2018 Nov 9. Review

March 2019

• Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
  Brown HK, Tellez-Gabriel M, Cartron PF, Vallette FM, Heymann MF, Heymann D. Drug Discov Today. 2019 Mar;24(3):763-772. doi: 10.1016/j.drudis.2018.11.017.

February 2019

• EMT is associated with an epigenetic signature of ECM remodelling genes.
  Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C, Feugeas JP, Herfs M, Boyer-Guittaut M, Hervouet E. Cell Death Dis. 2019 Feb 27;10(3):205

January 2019

• Epigenetic protein complexes: the adequate candidates for the use of a new generation of epidrugs in personalized and precision medicine in cancer.
  Cartron PF, Cheray M, Bretaudeau L.
  Epigenomics. 2020 Jan;12(2):171-177. doi: 10.2217/epi-2019-0169.

• Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma.
  Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF.
  Clin Epigenetics. 2018 Feb 9;10:17. doi: 10.1186/s13148-018-0450-y. eCollection 2018. Review.

• Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ Hybridization. Moukengue B, Amiaud J, Jacques C, Charrier C, Ory B, Lamoureux F. Methods Mol Biol. 2019;1914:169-196.